Non Hodgkin lymphoma (NHL)
Clinical trials for Non Hodgkin lymphoma (NHL) explained in plain language.
Never miss a new study
Get alerted when new Non Hodgkin lymphoma (NHL) trials appear
Sign up with your email to follow new studies for Non Hodgkin lymphoma (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new immune cell therapy outsmart resistant blood cancers?
Cure Not yet recruitingThis Phase 2 trial is testing an experimental therapy called LMY-920, which uses a patient's own immune cells (T cells) engineered to recognize and attack cancer cells through a protein called BAFF. The study aims to see if this treatment can shrink tumors or eliminate signs of c…
Matched conditions: NON HODGKIN LYMPHOMA (NHL)
Phase 2 • Sponsor: Luminary Therapeutics • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
Ready-Made immune cells take on blood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new cell therapy called ALA-101 for people with CD19+ non-Hodgkin lymphoma or leukemia. The therapy uses donor immune cells that are specially designed to find and attack cancer cells. The main goals are to check safety and find the best dose, with …
Matched conditions: NON HODGKIN LYMPHOMA (NHL)
Phase 1 • Sponsor: Arovella Therapeutics Ltd • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC